Molecular Mechanisms of Genetic Deregulation in Toxicity and Carcinogenesis July 20-25,1991,The Gant Conference Center,Aspen,Colorado

Kunkel T. (1985). The mutational specificity of DNA polymerase-β during in vitro DNA synthesis: Production of frameshift, base substitution and deletion mutations. J. Biol. Chem. 260: 5787-5796.

Lindahl T. and Nyberg B. (1972). Rate of depurination of native deoxyribonucleic acid. Biochemistry 11: 3610-3618.

Loeb LA and Preston B. (1986). Mutagenesis by apurinic/apyrimidinic sites. Annu. Rev. Genet. 20: 201-230.

Tkeshelashvili L. , McBride T. , Spence K. , and Loeb L. (1991). Mutation spectrum of copper-induced DNA damage. J. Biol. Chem . 266: 6601-6406.

Boyer J. , Kaufmann WK , and Cordeiro-Stone M. (1991). Role of post-replication repair in transformation of human fibroblasts to anchorage independence. Cancer Res. 51: 2960-2964.

Cordeiro-Stone M. , Doggett NA , Laundon CH , and Kaufman DG (1991). Timing of proto-oncogene replication and its relationship to transformation sensitivity to chemical carcinogens. In: Growth Regulation and Carcinogenesis, WR Paukovits (ed). CRC Press, Boca Raton, FL, pp. 131-142.

Doggett NA , Cordeiro-Stone M. , Chae C-B. , and Kaufman DG (1988). Timing of proto-oncogene replication: A possible determinant of early S phase sensitivity of C3H 10T1/2 cells to transformation by chemical carcinogens. Molecular Carcinogenesis 1: 41-49.

Kaufman DG and Cordeiro-Stone M. (1991). The roles of cell proliferation and gene replication in neoplastic transformation. In: Growth Regulation and Carcinogenesis, WR Paukovits (ed). CRC Press, Boca Raton, FL, pp. 143-152.

Kaufman DG and Cordeiro-Stone M. (1990). Variations in susceptibility to initiation of carcinogenesis during the cell cycle. In: Transformation of Human Diploid Fibroblasts: Molecular and Genetic Mechanisms , GE Milo (ed). CRC Press, Boca Raton, FL, pp. 1-27.

Kaufmann WK (1989). Pathways of human cell post-replication repair . Carcinogenesis 10: 1-11.

Kaufmann WK , MacKenzie SA , and Kaufman DG (1987). Factors influencing the initiation by gamma rays of hepatocarcinogenesis in the rat. Teratogenesis, Carcinogenesis and Mutagenesis 7: 551-556.

Kaufmann WK , Rahija RJ , MacKenzie SA , and Kaufman DG (1987). Cell cycle-dependent initiation of hepatocarcinogenesis in rats by (±)-7γ,8t-dihydroxy-9t, 10t-epoxy-2,8,9,10-tetrahydrobenzo[a]pyrene . Cancer Res. 47: 3771-3775.

Kaufmann WK , Rice JM , Wenk ML , Devor D. , and Kaufman DG (1987). Cell cycle-dependent initiation of hepatocarcinogenesis in rats by methyl(acetoxymethyl)nitrosamine. Cancer Res. 47: 1263-1266.

Paules RS , Cordeiro-Stone M. , Mass MJ , Poirier MC , Yuspa SH , and Kaufman DG (1988). Benzo[a]pyrene-diol-epoxide-I binds to DNA at replication forks. Proc. Natl. Acad. Sci. USA 85: 2176-2180.

Blackwell TK and Alt FW (1989). Mechanism and developmental program of immunoglobulin gene rearrangements in mammals . Ann. Rev. Genetics 23: 605-636.

Oettinger MA , Schatz DG , Gorka C. , and Baltimore D. (1990). RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination . Science 248: 1517-1523.

Ashall F. and Puck TT (1984). Cytoskeletal involvement in cAMP-induced sensitization of chromatin to nuclease digestion in transformed Chinese hamster ovary K1 cells. PNAS USA 81: 5145-5149.

Garel A. , Zolan M. , and Axel R. (1977). Genes transcribed at diverse rates have a similar conformation in chromatin. PNAS USA 74: 4867-4871.

Hsie AW and Puck TT (1971). Morphological transformation of Chinese hamster cells by dibutyryl adenosine cyclic 3':5'-monophosphate and testosterone. PNAS USA 68: 358-361.

Hutchison N. and Weintraub H. (1985). Localization of DNAase I-sensitive sequences to specific regions of interphase nuclei. Cell 43: 471-482.

Krystosek A. and Puck TT (1989). Genome exposure in reverse transformation. J. Cell Biol. 109:231a (Abstract).

Krystosek A. and Puck TT (1990). The spatial distribution of exposed nuclear DNA in normal, cancer, and reverse transformed cells. PNAS USA 87: 6560-6564.

Puck TT (1979). Studies on cell transformation. Somat. Cell Genet. 5: 973-990.

Puck TT and Krystosek A. (1991). The role of the cytoskeleton in genome regulation and cancer. Int. Rev. Cytol. (in press).

Puck TT , Krystosek A. , and Chan D. (1990). Genome regulation in mammalian cells. Somat. Cell Molec. Genet. 16: 257-265.

Weintraub H. and Groudine M. (1976). Chromosomal subunits in active genes have an altered conformation. Science 1983: 848-856.

Belmont LD , Hyman AA , Sawin KE , and Mitchison TJ (1990). Real-time visualization of cell cycle-dependent changes in microtubule dynamics in cytoplasmic extracts. Cell 62: 579-589.

Dustin P. (1984). Microtubules. Springer-Verlag , New York.

Endow SA and Hatsumi M. (1991). A multimember kinesin gene family in Drosophila . Proc. Natl. Acad. Sci. USA 88: 4424-4427.

Sawin KE and Mitchison TJ (1991). Mitotic spindle assembly by two different pathways in vitro. J. Cell Biol. 112: 925-940.

Sawin KE and Mitchison TJ (1991). Poleward microtubule flux in mitotic spindles assembled in vitro. J. Cell Biol. 112: 941-954.

Masui Y. and Markert CL (1971). Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J. Exp. Zool. 177: 129-146.

Meyerhof PG and Masui Y. (1977). Ca and Mg control of cytostatic factors from Rana pipiens oocytes which cause metaphase and cleavage. Dev. Biol . 61: 214-229.

Murray AW and Kirschner MW (1989). Dominoes and clocks: the union of two views of the cell cycle. Science 246: 614-621.

O'Keefe SJ , Wolfes H. , Kiessling AA , and Cooper GM (1989). Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg. Proc. Natl. Acad. Sci. USA 86: 7038-7042.

Paules RS , Buccione R. , Moschel RC , Vande Woude GF , and Eppig JJ (1989). Mouse Mos proto-oncogene product is present and functions during oogenesis. Proc. Natl. Acad. Sci. USA 86: 5395-5399.

Propst F. and Vande Woude GF (1985). c-mos proto-oncogene transcripts are expressed in mouse tissues. Nature 315: 516-518.

Sagata N. , Oskarsson M. , Copeland T. , Brumbaugh J. , and Vande Woude GF (1988). Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature 335: 519-525.

Sagata N. , Watanabe N. , Vande Woude GF , and Ikawa Y. (1989). The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature 342: 512-518.

Watanabe N. , Vande Woude GF , Ikawa Y. , and Sagata N. (1989). Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs. Nature 342: 505-511.

Zhou R. , Oskarsson M. , Paules RS , Schulz N. , Cleveland D. , and Vande Woude GF (1991). Ability of the c-mos product to associate with and phosphorylate tubulin. Science 251: 671-675.

Bishop JM (1991). Molecular themes in oncogenesis. Cell 64: 235-248.

Blackwood EM and Eisenman RN (1991). Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc . Science 251: 1211-1217.

Eilers M. , Schirm S. , and Bishop JM (1991). The Myc protein activates transcription of the α-prothymosin gene. EMBO J. 10: 133-141.

Johnson PF and McKnight SL (1989). Eukaryotic transcriptional regulatory proteins . Ann. Rev. Biochem. 58: 799-841.

Luscher B. and Eisenman RN (1990). New light on Myc and Myb. Part I. Myc. Genes Dev. 4: 2025-2035.

Luscher B. and Eisenman RN (1990). New light on Myc and Myb. Part II. Myb. Genes Dev. 4: 2235-2241.

Prendergast GC , Lawe D. , and Ziff EB (1991). Association of myn, the murine homolog of max, with c-myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65: 395-407.

Barbacid M. (1987). Ras genes. Annu. Rev. Biochem . 56: 779-827.

Bollag G. and McCormick F. (1991). Distinct ras GAP activities in clonal cells. Nature (in press).

Bos JL (1988). The ras family and human carcinogenesis. Mutat. Res. 195: 255-271.

Bourne HR , Sanders DA , and McCormick F. (1990). The GTPase superfamily: A conserved switch for diverse cell functions. Nature 348: 125-131.

Bourne HR , Sanders DA , and McCormick F. (1991). The GTPase superfamily: Conserved structure and molecular mechanism. Nature 349: 117-127.

Gibbs JB (1991). Ras C-terminal processing enzymes-New drug targets ? Cell 65: 1-4.

Xu G. , O'Connell P. , Viskochil D. , Cawthon R. , Robertson M. , Culver M. , Dunn D. , Stevens J. , Gesteland R. , White R. , and Weiss R. (1990). The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599-608.

Baker SJ , Markowitz S. , Fearon ER , Willson JK , and Vogelstein B. (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915.

Baker SJ , Preisinger AC , Jessup JM , Paraskeva C. , Markowitz S. , Willson JK , Hamilton S. , and Vogelstein B. (1990). p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectaltumorigenesis. Cancer Res. 50: 7717-7722.

Bartek J. , Iggo R. , Gannon J. , and Lane DP (1990). Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5: 893-899.

Bressac B. , Kew M. , Wands J. , and Ozturk M. (1991). Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-431.

Chiba I. , Takahashi T. , Nau MM , D'Amico D. , Curiel DT , Mitsudomi T. , Buchhagen DL , Carbone D. , Piantadosi S. , Koga H. , Reissman PT , Slamon DJ , Holmes EC , and Minna JD (1990). Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5: 1603-1610.

DeCaprio JA , Ludlow JW , Figge J. , Shew JY , Huang CM , Lee WH , Marsilio E. , Paucha E. , and Livingston DM (1988). SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275-283.

Diller L. , Kassel J. , Nelson CE , Gryka MA , Litwak G. , Gebhardt M. , Bressac B. , Ozturk M. , Baker SJ , Vogelstein B. , and Friend SH (1990). p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10: 5772-5781.

Eliyahu D. , Raz A. , Gruss P. , Givol D. , and Oren M. (1984). Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 312: 646-649.

Finlay CA , Hinds PW , Tan TH , Eliyahu D. , Oren M. , and Levine AJ (1988). Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life . Mol. Cell. Biol. 8: 531-539.

Hinds P. , Finlay C. , and Levine AJ (1989). Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J. Virol. 63: 739-746.

Hollstein M. , Metcalf RA , Welsh J. , Montesano R. , and Harris CC (1990). Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA 87: 9958-9961.

Hollstein M. , Sidransky D. , Vogelstein B. , and Harris CC (1991). p53 mutations in human cancers. Science (in press).

Hsu IC , Metcalf RA , Sun T. , Welsh J. , Wang NJ , and Harris CC (1991). p53 gene mutational hotspot in human hepatocellular carcinomas from Qidong, China. Nature 350: 427-428.

Iggo R. , Gatter K. , Bartek J. , Lane D. , and Harris AL (1990). Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335: 675-679.

Maher VM , Yang JL , Mah MC , and McCormick JJ (1989). Comparing the frequency and spectra of mutations induced when an SV-40 based shuttle vector containing covalently bound residues of structurally-related carcinogens replicates in human cells. Mutat. Res. 220: 83-92.

Malkin D. , Li FP , Strong LC , Fraumeni JF , Nelson CE , Kim DH , Kassel J. Gryka MA , Bischoff FZ , Tainsky MA , and Friend SH (1990). Germ line p53 mutations in a familiar syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238.

Mazur M. , Gordon AJF , Bernelot-Moens C. , and Glickman BW (1989). Comparison of the mutational specificities exhibited by BPDE in Escherichia coli and CHO cells. In: DNA Repair Mechanisms and their Biological Implications in Mammalian Cells, MW Lambert and J Laval (eds). Plenum Publishing Corp., New York.

McMahon G. , Davis EF , Huber LJ , Kim Y. , and Wogan GN (1990). Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors. Proc. Natl. Acad. Sci. USA 87: 1104-1108.

Naylor SL , Johnson BE , Minna JD , and Sakaguchi AY (1987). Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 329: 451-454.

Nigro JM , Baker SJ , Preisinger AC , Jessup JM , Hostetter R. , Cleary K. , Bigner SH , Davidson N. , Baylin S. , Devilee P. , Glover T. , Collins FS , Weston A. , Modali R. , Harris CC , and Vogelstein B. (1989). Mutations in the p53 gene occur in diverse human tumor types. Nature 342: 705-708.

Rogel A. , Popliker M. , Webb CG , and Oren M. (1985). p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol. Cell. Biol . 5: 2851-2855.

Soussi T. , Caron de Fromentel C. , and May P. (1990). Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5: 945-952.

Vogelstein B. (1990). Cancer. A deadly inheritance . Nature 348: 681-682.

Weston A. , Willey JC , Modali R. , Sugimura H. , Mc-Dowell EM , Resau J. , Light B. , Haugen A. , Mann DL , Trump BF , and Harris CC (1989). Differential DNA sequence deletions from chromosomes 3, 11, 13 and 17 in squamous cell carcinoma, large cell carcinoma and adenocarcinoma of the human lung. Proc. Natl. Acad. Sci. USA 86: 5099-5103.

Yokota J. , Wada M. , Shimosato Y. , Terada M. , and Sugimura T. (1987). Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung . Proc. Natl. Acad. Sci. USA 84: 9252-9256.

Haber D. and Housman D. (1991). Rate-limiting steps: The genetics of pediatric cancers. Cell 64: 5-8.

Rauscher III FJ et al (1990). Binding of the Wilms' tumor (WT1) protein to the Egr-1 consensus sequence. Science 250: 1259-1262.

Gillies RJ , Martinez-Zaguilan R. , Martinez GM , Serrano R. , and Perona R. (1990). Tumorigenic 3T3 cells maintain an alkaline intracellular pH under the physiological conditions. Proc. Natl. Acad. Sci. USA 87: 7414-7418.

Gillies RJ and Martinez-Zaguilan R. (1990). Regulation of intracellular pH in BALB/c 3T3 cells: Bicarbonate raises pH via NaHCO3/HCl exchange and attenuates the activation of Na+/H+ exchange by serum. J. Biol. Chem. 266: 1551-1556.

Moolenaar WH (1986). Effects of growth factors on intracellular pH regulation. Ann. Rev. Physiol. 48: 363-376.

Muldoon LL , Jamieson GA , Kao AC , Palfrey HC , and Villereal ML (1987). Mitogen stimulation of Na+/H+ exchange: Differential involvement of protein kinase C. Am. J. Physiol. 253: C219-C229.

Perona R. and Serrano R. (1988). Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pump. Nature 334: 438-440.

Perona R. , Portillo F. , Giraldez F. , and Serrano R. (1990). Transformation and pH homeostasis of fibroblasts expressing yeast H+-ATPase containing site-directed mutations. Mol. Cell. Biol. 10: 4110-4115.

Roos A. and Boron WF (1981). Intracellular pH. Physiol. Rev . 61: 296-434.

Assoian RK , Frolik CA , Roberts AB , Miller DM , and Sport MB (1984). Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblasts. Cell 36: 35-41.

Ke Y. , Reddel RR , Gerwin BI , Miyashita M. , McMenamin MG , Lechner JF , and Harris CC (1988). Human bronchial epithelial cells with integrated SV40 virus T-antigen genes retain the ability to undergo squamous differentiation . Differentiation 38: 60-66.

Laiho M. , Saksela O. , Andreasen PA , and Keski-Oja J. (1986). Enhanced production and extracellular deposition of endothelial-type plasminogen activator in cultured human lung fibroblasts by transforming growth factor-beta. J. Cell Biol. 103: 2403-2410.

Massague J. (1985). Transforming growth factor-β modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-α. J. Cell Biol. 100: 1508-1514.

Pietenpol JA , Holt JT , Stein RW , and Moses HL (1990). Transforming growth factor β1 suppression of c-myc gene transcription: Role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. USA 87: 3758-3762.

Reddel RR , Ke Y. , Gerwin BI , McMenamin MG , Lechner JF , Su RT , Brash DE , Park JB , Rhim JS , and Harris CC (1988). Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48: 1904-1909.

Housey GM , Johnson MD , Wendy Hsiao WL , O'Brian CA , Murphy JP , Kirschmeyer P. , and Weinstein IB (1988). Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52: 343-354.

Hsiao W-LW et al (1989). Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene. Mol. Cell. Biol. 9: 2641-2647.

Gillies RJ , Martínez-Zaguilán R. , Martinez GM , Serrano R. , and Perona R. (1990). Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions. Proc. Natl. Acad. Sci. USA 87: 7414-7418.

Perona R. and Serrano R. (1988). Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pump. Nature 334: 438-440.

Mohapatra N. , MacNair P. , Bryant BJ , Ellis S. , Rudo K. , Sangaiah R. , Gold A. , and Nesnow S. (1987). Morphological transforming activity and metabolism of cyclopenta-fused isomers of benz[a]anthracene in mammalian cells. Mutat. Res. 188: 323-334.

Nesnow S. , Gold A. , Sangaiah R. , Triplett L. , and Slaga TJ (1984). Mouse skin tumor-initiating activity of benz[e]aceanthrylene and benz[1]aceanthrylene in SENCAR mice. Cancer Lett. 22: 263-268.

Nesnow S. , Lasley J. , Curti S. , Ross J. , Nelson G. , Sangaiah R. , and Gold A. (1991). Morphological transformation and DNA adduct formation by benz[j]aceanthrylene and its metabolites in C3H10T1/ 2CL8 cells: Evidence for both cyclopenta-ring and bay region metabolic activation pathways. Cancer Res. (in press).

Nesnow S. , Leavitt S. , Easterling R. , Watts R. , Toney SH , Claxton L. , Sangaiah R. , Toney GE , Wiley J. , Fraher P. , and Gold A. (1984). Mutagenicity of cyclopenta-fused isomers of benz[a]anthracene in bacterial and rodent cells and identification of the major rat liver microsomal metabolites. Cancer Res. 44: 4993-5003.

Adelman R. , Saul RL , and Ames BN (1988). Oxidative damage to DNA: Relation to species metabolic rate and life span. Proc. Nat. Acad. Sci. USA 85: 2706-2708.

Beyer W. , Imlay J. , and Fridovich I. (1991). Superoxide dismutases. Prog. Nucl. Acids Res. 40: 221-253.

Fridovich I. (1989). Superoxide dismutases. An adaptation to a paramagnetic gas. J. Biol. Chem. 264: 7761-7764.

Gardner PR and Fridovich I. (1991). Superoxide sensitivity of the Escherichia coli 6-phosphogluconate dehydratase. J. Biol. Chem. 266: 1478-1483.

Gardner PR and Fridovich I. (1991). Superoxide sensitivity of the Escherichia coli aconitase. J. Biol. Chem. (submitted).

Hassan HM (1989). Microbial superoxide dismutases. Advan. Genet. 26: 65-97.

Imlay JA and Fridovich I. (1991). Assay of metabolic superoxide production in Escherichia coli. J. Biol. Chem. 266: 6957-6965.

Kuo CF , Mashino T. , and Fridovich I. (1987). α,β-Dihydroxy isovalerate dehydratase. A superoxide-sensitive enzyme. J. Biol. Chem. 262: 4724-4727.

Levin JD , Johnson AW , and Demple B. (1988). Homogeneous Escherichia coli endonuclease. IV. Characterization of an enzyme that recognizes oxidative damage to DNA. J. Biol. Chem. 263: 8066-8071.

Richter C. , Park JW , and Ames BN (1988). Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Nat. Acad. Sci. USA 85: 6465-6467.

Touati D. (1989). The molecular genetics of superoxide dismutases in Escherichia coli. An approach to understanding the biological role and regulation of superoxide dismutases in relation to other elements of the defense system against oxygen toxicity. Free Rad. Res. Commun. 8: 1-9.

Cerutti PA (1991). Oxidant stress and carcinogenesis. Eur. J. Clin. Invest. 21: 1-5.

Cerutti PA and Trump BF (1991). Inflammation and oxidative stress in carcinogenesis . Cancer Cells 3: 1-7.

Beckmann RP , Mizzen LA , and Welch WJ (1991). Interaction of hsp 70 with newly synthesized proteins: Implications for protein folding and assembly events. Science 248: 850-854.

Chirico WJ , Waters MG , and Blobel G. (1988). 70k heat shock related proteins stimulated protein translocation into microsomes. Nature 333: 805-810.

Deshaies RJ , Koch BD , Weiner-Washburne M. , Craig E. , and Schekman R. (1988). A subfamily of stress proteins facilitates translocation of secretory and mitochondrial precursor polypeptides. Nature 332: 800-805.

Georgopoulos C. and Ang D. (1990). Properties of the Escherichia coli heat shock proteins and their role in bacteriophage X growth in stress proteins in biology and medicine. In: Stress Proteins in Biology and Medicine, R Morimoto , A Tissieres , and C Georgopoulos (eds). Cold Spring Harbor Laboratories, Cold Spring Harbor, NY, pp. 191-222.

Gerner EW and Scheider MJ (1975). Induced thermal resistance in Hela cells. Nature 256: 500-502.

Hemmingsen SM , Woolford C. , Vardervies SM , Tilly K. , Dennie DJ , Georgopoulos C. , Hendrix RW , and Willis RJ (1988). Homologous plant and bacterial proteins chaperone oligomeric protein assembly . Nature 333: 330-334.

Kang P. , Ostermann J. Shilling J. , Neupert W. , Craig E. , and Pfanner N. (1990). Requirement for hsp 70 in the mitochondrial matrix for translocation and folding of precursor proteins. Nature 348: 137-143.

Mizzen LA , Kabiling AN , and Welch WJ (1991). The two mammalian mitochondrial stress proteins, grp 75 and hsp 58, transiently interact with newly synthesized mitochondrial proteins. Cell Regulation 2: 165-179.

Morimoto R , Tissieres A , and Georgopoulos C (eds) (1990). Stress Proteins in Biology and Medicine. Cold Spring Harbor Press, Cold Spring Harbor, NY.

Vogel JP , Misra LM , and Rose MD (1990). Loss of BiP/GRP 78 function blocks translocation of secretory proteins in yeast. J. Cell Biol. 110: 1885-1895.

Welch WJ and Feramisco JR (1985). Rapid purification of mammalian 70,000-dalton stress proteins: Affinity of the proteins for nucleotides. Mol. Cell. Biol. 5: 1229-1237.

Welch WJ , Garrels JI , Thomas GP , Lin JJ , and Feramisco JR (1983). Biochemical characterization of the mammalian stress proteins and identification of two stress proteins as glucose- and Ca2+ ionophore-regulated proteins. J. Biol. Chem. 258: 7102-7111.

Goosen JA , de Leeuw WJ , Tan CH , Zwarthoff EC , Berends F. , Lohman PH , Knook DL , and Vijg J. (1989). Efficient rescue of integrated shuttle vectors from transgenic mice: A model for studying mutations in vivo. Proc. Natl. Acad. Sci. USA 86(20): 7971-7975.

Griesemer R. and Tennant RW (1991). Transgenic animals in carcinogenicity testing . International Agency for Research in Cancer (IARC) Scientific Publications (in press).

Leder A. , Kuo A. , Cardiff RD , Sinn E. , and Leder P. (1990). v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA 87(23): 9178-9182.

Pattengale PK , Stewart TA , Leder A. , Sinn E. , Muller W. , Tepler I. , Schmidt E. , and Leder P. (1989). Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. Am. J. Pathol. 135(1): 39-61.

Stewart TA , Pattengale PK , and Leder P. (1984). Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38(3): 627-637.

LeBoeuf RA and Kerckaert GA (1986). The induction of transformed-like morphology and enhanced growth in Syrian hamster embryo cells grown at acidic pH. Carcinogenesis (London) 7: 1431-1440.

LeBoeuf RA and Kerckaert GA (1987). Enhanced morphological transformation of early passage Syrian hamster embryo cell cultures in medium with a reduced bicarbonate concentration and pH. Carcinogenesis ( London) 8: 689-697.

LeBoeuf RA , Kerckaert GA , Aardema MJ , and Gibson DP (1990). Multi-stage neoplastic transformation of Syrian hamster embryo cell cultures at pH 670 .Cancer Res.50: 3722-3729.

Ruch RJ , Klaunig JE , and LeBoeuf RA (1990). Modification of gap junctional intercellular communication by changes in extracellular pH in Syrian hamster embryo cells. Carcinogenesis 11: 909-913.

Bailar JC III (1991). How dangerous is dioxin? N. Engl. J. Med. 234: 260-262.

Poland A. and Knutson JC (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related aromatic hydrocarbons: Examination of the mechanism of toxicity. Ann. Rev. Pharmacol. Toxicol. 22: 517-554.

Whitlock JP Jr (1990). Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Ann. Rev. Pharmacol. Toxicol. 30: 251-277.

Crissman HA , Gadbois DM , Tobey RA , and Bradbury EM (1991). Loss of kinase-mediated regulation of G1 phase progression in transformed mammalian cells. Proc. Natl. Acad. Sci. USA (in press, September issue).

Terada M. , Yoshida T. , Sakamoto H. , Hattori Y. , lida S. , Yamada Y. , Yokota J. , Katoh O. , Hirohashi S. , and Sugimura T. (1991). Heparin-binding growth factor genes, hat-1 and hst-2/FGF6. In: Origins of Human Cancer. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY (in press).

Tsuda T. , Nakatani H. , Matsumira T. , Yoshida K. Tahara E. , Nishihira T. , Sakamoto H. , Yoshida T. , Terada M. , and Sugimura T. (1988). Amplification of the hst-1 gene in human esophageal carcinomas. Jpn. J. Cancer Res. 79: 584-588.

Wada M. , Yokota J. , Mizoguchi H. , Sugimura T. , and Terada M. (1988). Infrequent loss of chromosomal heterozygosity in human stomach cancer. Cancer Res. 48: 2988-2992.

Yamada H. , Yoshida T. , Sakamoto H. , Terada M. , and Sugimura T. (1986). Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplification of both c-myc and activated c-ki-ras by a point mutation. Biochem. Biophys. Res. Commun. 140: 167-173.

Yokota J. , Nada M. , Shimosato Y. , Terada M. , and Sugimura T. (1987). Loss of heterozygosity on chromosomes 3, 13 and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung . Proc. Natl. Acad. Sci. USA 84: 9252-9256.

Alavanja MJ , Aron J. , Brown C. , and Chandler J. (1987). Biochemical epidemiology: Potential contributions to cancer risk assessment. J. Natl. Cancer Inst. 78: 633-643.

Bartlett MS (1990). Chance or chaos. JR Statist Soc . 153: 321-347.

Chandler JLR (1973). Chemical kinetic model of mutation induction. Mutat. Res. 25: 169-176.

Chandler JLR (1985). New mechanistic models for risk assessment. Fundam. Appl. Toxicol. 5: 634-652.

Chandler JLR (1990). Causality in toxicologic risk assessment and risk management. In: New Risks, LA Cox and PF Ricci (eds). Plenum Press, New York, pp. 45-53.

Chandler JLR (1991). Distributions of biochemical cause effect relationships in human populations. Am. J. Ind. Med. (in press).

Degn H. , Holden AV , and Olsen LF (1987). Chaos in Biological Systems. Plenum Press, New York.

Dosemeci M. , Blair A. , Stewart PA , Chandler JLR , and Trush MA (1991). Mortality among industrial workers exposed to phenol. Epidemiology 2(3): 188-193.

Glass L. and Mackey MC (1988). From Clocks to Chaos: The Rhythms of Life, 1st ed. Princeton University Press, Princeton.

Moolgavkar S. (1990). Scientific Issues in Quantitative Risk Analysis. Birkhauser, Boston .

Rensing L. , an der Heiden U. , and Makey MC (1986). Temporal Disorders in Human Oscillatory Systems . Springer-Verlag, Heidelberg.

Schuster HG (1987). Deterministic Chaos. VCH, Weinheim, FRG.

Voit EO (1991). Canonical Nonlinear Models. S System Approach to Understanding Complexity. Van Nostrand Reinhold, New York.

Dlugosz AA and Yuspa SH (1991). Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro . Cancer Res. (in press).

Gschwendt M. , Furstenberger G. , Rose-John S. , Rogers M. , Kittstein W. , Pettit GR , Herald CL , and Marks F. (1988). An activator of protein kinase C mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro. Carcinogenesis 9: 555-562.

Sako T. , Tauber AI , Jeng AY , Yuspa SH , and Blumberg PM (1988). Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cells . Cancer Res. 48: 4646-4650.

Sako T. , Yuspa SH , Herald CL , Pettit GR , and Blumberg PM (1987). Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells . Cancer Res. 47: 5445-5450.

Strickland JE , Dlugosz AA , Hennings H. , and Yuspa SH (1991). Staurosporine inhibits tumor formation from grafted mouse papilloma cell lines . Proc. Am. Assoc. Cancer Res. 32: 127.

Tamaoki T. , Nomoto H. , Takahashi I. , Kato Y. , Morimoto M. , and Tomita F. (1986). Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochem. Biophys. Res. Commun. 135: 397-402.

Yamada S. , Hirota K. , Chida K. , and Kuroki T. (1988). Inhibition of phorbol ester-caused induction of ornithine decarboxylase and tumor promotion in mouse skin by staurosporine, a potent inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 157: 9-15.

Yamamoto S. , Kiyoto I. , Aizu E. , Nakadate T. , Hosoda Y. , and Kato R. (1989). Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarbosylase induction, hyperplasia and inflammation. Carcinogenesis 10: 1315-1233.

Yoshizawa S. , Fujiki H. , Suguri H. , Suganuma M. , Nakayasu M. , Matsushima R. , and Sugimura T. (1990). Tumor-promoting activity of staurosporine, a protein kinase inhibitor on mouse skin. Cancer Res. 50: 4974-4978.

Yuspa SH , Ben T. , Hennings H. , and Lichti U. (1982). Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 42: 2344-2349.

Rostein JB , O'Connell JF , and Slaga TJ (1987). A possible role for free radicals in tumor progression . In: Anticarcinogenesis and Radiation Protection, PA Cerutti , OF Nygaard , and MG Semic (eds). Plenum Publishing Corp, NY, pp. 211-219.

Slaga TJ (1983). Cellular and molecular mechanisms of tumor promotion . Cancer Surv. 2(4): 595-612.

Slaga TJ , O'Connell J. , Rotstein J. , Patskan G. , Morris R. , Aldaz M. , and Conti C. (1987). Critical genetic determinants and molecular events in multi-stage skin carcinogenesis. Sym. of Fund. Cancer Res . 39: 31-44.

Barbacid M. (1990). Ras oncogenes: Their role in neoplasia. Eur. J. Clin. Investi. 20: 225-235.

Brown D. , Yu ZP , Miller P. , Blake K. , Wei C. , Kung HF , Black R. , Ts'o POP , and Chang EH (1989). Modulation of ras expression by antisense, nonionic deoxyoligonucleotide analogs. Oncogene Res. 4: 243-252.

Chang EH , Yu ZP , Shimizuka K. , Wilson WD , Strekowska A. , and Zon G. (1989). Comparison of efficacy of modified anti-ras olilgodeoxynucleotides . AntiCancer Drug Design 4: 221-232.

Miller PS and Ts'o POP (1988). Oligonucleotide inhibitors of gene expression in living cells: New opportunities in drug design. Annual Reports in Med. Chem. 23: 295-304.

Bhan P. and Miller PS (1990). Photo-cross-linking of psoralen-derivatized oligonucleoside methylphosphonates to single-stranded DNA. Bioconjugate Chemistry 1: 82-88.

Saison-Behmoaras T. , Tocque B. , Rey I. , Chassignol M. , Thuong NT , and Helene C. (1991). Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation . EMBO 10: 1111-1118.

Borner C. , Nichols SF , Hsieh L. -L, Hsiao WL , and Weinstein IB (1990). Transformation by a ras oncogene causes increased expression of PKCα and decreased expression of PKC∈. Cell Growth and Differentiation 1: 653-660.

Choi PM , Tchou-Wong KM , and Weinstein IB (1990). Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol. Cell Biol. 10: 4650-4657.

Kahn SM , Jiang W. , Culbertson TA , Weinstein IB , Williams GM , and Ronai Z. (1991). Rapid and sensitive nonradioactive detection of mutant K-ras genes via selective PCR amplification. Oncogene 6: 1079-1083.

Morotomi M. , Guillem JG , LoGerfo P. , and Weinstein IB (1990). Production of diacylglycerol, an activator of protein kinase C, by intestinal microflora. Cancer Res. 50: 3595-3599.

Phan S-C. , Morotomi M. , Guillem JG LoGerfo P. , and Weinstein IB (1991). Decreased levels of 1,2-sn-diacylglycerol in human colon tumors. Cancer Res. 51: 1571-1573.

Weinstein IB , Bomer CM , Krauss RS , O'Driscoll K. , Choi PM , Morotomi M. , Hoshina S. , Hsieh L-L. , Tchou-Wong K-M. , Guadagno Nichols S. , Ueffing M. , and Guillem JG (1991). Pleiotropic effects of protein kinase C and the concept of carcinogenesis as a progressive disorder in signal transduction . In: Origins of Human Cancer: A Comprehensive Review, J. Brugge , T. Cur-ran , E. Harlow , and F. McCormick (eds). Cold Spring Harbor Laboratory Press, NY, pp. 113-124.

Liber HL , Benforado K. , Crosby RM , Simpson D. , and Skopek TR (1989). Formaldehyde-induced and spontaneous alterations in human hprt DNA sequence and mRNA expression. Mutat. Res . 226: 31-37.

Nicklas JA , O'Neill JP , Sullivan LS , Hunter TC , Allegretta M. , Chastenay BF , Libbus BL , and Albertini RJ (1988). Molecular analysis of in vivo hprt mutations in human t-lymphocytes. II. Demonstration of a clonal amplification of hprt mutants in vivo. Environ. and Mol. Mutag. 12: 271-284.

Recio L. , Cochrane J. , Simpson D. , Skopek TR , O'Neill JP , Nicklas JA , and Albertini RJ (1990). DNA sequence analysis of in vivo hprt mutation in human T-lymphocytes. Mutagenesis 5: 505-510.

Recio L. and Skopek TR (1988). Mutagenicity of acrylonitrile and its metabolite 2-cyanoethylene oxide in human lymphoblasts and E. coli. Mutat. Res. 206: 297-305.

Simpson D. , Crosby RM , and Skopek TR (1988). A method for specific cloning and sequencing of human HPRT cDNA for mutation analysis. Biochem. Biophys. Res. Comm. 151(1): 487-492.

Ayesh R. , Idle JR , Ritchie JC , Crothers MJ , and Hetzel MR (1984). Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312: 169-170.

Caporaso N. , Hayes RB , Dosemeci M. , Hoover R. , Ayesh R. , Hetzel M. , and Idle JR (1989). Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res. 49: 3675-3679.

Caporaso NE , Tucker MA , Hoover R. , Hayes RB , Pickle LW , Issaq H. , Muschik G. , Green-Gallo L. , Buivys D. , Aisner S. , Resau J. , Trump BF , Tollerud D. , Weston A. , and Harris CC (1990). Lung cancer and the debrisoquine metabolic phenotype . J. Natl. Cancer Inst. 85: 1264-1272.

Heim M. and Meyer UA (1990). Genotyping of poor metabolizers of debrisoquine by allele-specific PCR amplification. Lancet 336: 529-532.

Kawajiri K. , Nakachi K. , Imai K. , Yoshii A. , Shinoda N. , and Watanabe J. (1990). Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS 263: 131-133.

Kouri RE , McKinney CE , Slomiany DJ , Snodgrass DR , Wray NP , and McLemore TL (1982). Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res. 42: 5030-5037.

Petruzzelli S. , Camus AM , Carrozzi L. , Ghelarducci L. , Rindi M. , Menconi G. , Angeletti CA , Ahotupa M. , Hietanen E. , Aitio A. , Saracci R. , Bartsch H. , and Giuntini C. (1988). Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: A case-control study on lung cancer patients. Cancer Res. 48: 4695-4700.

Skoda RC , Gonzalez FJ , Demierre A. , and Meyer UA (1988). Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc. Natl. Acad. Sci. USA 85: 5240-5243.

Sugimura H. , Caporaso NE , Shaw GL , Modali RV , Gonzalez FJ , Hoover RN , Resau JH , Trump BF , Weston A. , and Harris CC (1990). Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls. Carcinogenesis 11: 1527-1530.

Aslanidis C. and de Jong PJ (1990). Ligation-independent cloning of PCR products (LIC-PCR). Nucleic Acids Res. 18: 6069-6074.

Branscomb E. , Slezak T. , Pae R. , Galas D. , and Waterman M. (1990). Optimizing restriction fragment fingerprinting methods for ordering large genomic libraries. Genomics 8: 351-366.

Carrano AV , de Jong PJ , Branscomb E. , Slezak T. , and Watkins BW (1989). Constructing chromosome- and region-specific cosmid maps of the human genome. Genome 31: 1059-1065.

Trask B. , Pinkel D. , and Van den Engh G. (1989). The proximity of DNA sequences in interphase cell nuclei is correlated to genomic distance and permits ordering of cosmids spanning 250 kilobase pairs. Genomics 5: 710-717.

Bansal N. , Houle A. , and Melnykovych G. (1991). Apoptosis: Mode of cell death induced in T cell leukemia lines by dexamethasone and other agents. FASEB J . 5: 211-216.

Bowen ID and Bowen SM (1990). Programmed Cell Death in Tumours and Tissues. Chapman and Hall, London.

Trump BF , Berezesky IK , Elliget KA , Smith MA , and Phelps PC (1990). Nephrotoxicity in vitro: Role of ion deregulation in signal transduction following injury-Studies utilizing digital imaging fluorescence microscopy. Toxic. In Vitro 4: 409-414.

Wyllie AH (1981). Cell death: A new classification separating apoptosis from necrosis. In: Cell Death in Biology and Pathology, ID Bowen and RA Lockshin (eds). Chapman and Hall, New York.

Helene C. and Toulme' J-J (1990). Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta 1049: 99-125.

Innis MI , Gelfand DH , Sninsky JJ , and White TJ (eds) (1990). PCR Protocols. Academic Press, San Diego .

Kinzler KW and Vogelstein B. (1989). Whole genome PCR: Application to the identification of sequences bound by gene regulatory proteins. Nucl. Acid Res. 17: 3645-3653.

Oliphant AO , Brandl CJ , and Struhl K. (1989). Defining the sequence specificity of DNA-binding proteins by selecting binding sites from random-sequence oligonucleotides: Analysis of yeast GCN4 protein. Mol. Cell. Biol. 9: 2944-2949.

Stein CA and Cohen JS (1988). Oligodeoxynucleotides as inhibitors of gene expression: A review. Cancer Res. 48: 2659-2668.

Weintraub HM (1990). Antisense RNA and DNA . Sci. Am. 262: 40-46.